# Minnesota Officials Recall Tidal Wave THC Vapes for Safety Concerns > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/tidal-wave-vape-recall-minnesota-high-thc-content/ > **Published:** 2026-03-20T17:49:39-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:43:11-04:00 > **Clinical Summary:** Minnesota's tidal wave vape recall highlights risks of high THC content in cannabis vapes, urging clinicians to counsel patients on safety and product verification. --- ✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicySafetyTHCIndustry Why This Matters Clinicians need to know that recalled cannabis products with unexpectedly high THC concentrations pose increased risks for acute adverse effects including psychosis, anxiety, and [cannabinoid hyperemesis](https://cedclinic.com/cannabis-hyperemesis-syndrome-virginia-er-cases-surge/) syndrome, particularly in patients with psychiatric vulnerability or those using vapes that deliver rapid THC absorption. Patients using these recalled products may experience more severe symptoms than anticipated based on labeled dosing, making it critical for clinicians to ask about specific product brands and batches when evaluating cannabis-related adverse events. This recall demonstrates the importance of counseling patients on regulatory gaps in cannabis product testing and the risks of purchasing from unverified sources. Clinical Summary Minnesota’s Office of Cannabis Management has issued a recall of Tidal Wave disposable vapes due to THC content exceeding state-mandated limits, highlighting ongoing quality control challenges in the regulated cannabis market. This recall underscores the importance of product testing and verification protocols designed to protect consumers from unintended overconsumption and potential adverse effects, particularly in markets where potency limits are established as a [public health](https://cedclinic.com/cannabis-mold-contamination-risks-safety-tips/) measure. For clinicians, such recalls represent a gap between regulatory oversight and retail practice that may affect patient safety and informed consent when patients purchase products they believe meet legal specifications. Patients using recalled products may have unknowingly consumed higher THC doses than intended, which could complicate symptom management or exacerbate conditions like anxiety or psychosis in vulnerable populations. Clinicians should remain aware of these compliance failures and counsel patients to verify product sourcing and check for official recalls before use. Patients should consult their state’s cannabis regulatory agency or dispensary records to determine if they have purchased affected products and discuss any unexpected symptoms with their healthcare provider. Dr. Caplan’s Take “When a product exceeds the legal THC limit by that margin, it tells me we have a serious quality control problem in this emerging market, and patients who think they’re getting a standardized dose are actually getting something substantially different, which undermines informed consent and safe dosing practices.” Clinical Perspective ⚕️ This Minnesota recall of Tidal Wave vapes exceeding legal THC limits highlights a critical gap between regulatory oversight and actual product safety in the cannabis market. While potency caps exist ostensibly to protect consumers—particularly younger users and those with lower tolerance—the recall itself reveals that testing and enforcement systems remain imperfect, and products noncompliant with labeling requirements may reach consumers before detection. Clinicians should be aware that patients using vaporized cannabis may unknowingly exceed their intended dose during this recall period, potentially experiencing acute effects such as anxiety, tachycardia, or impaired cognition that could complicate medical management or psychiatric presentations. Given that many patients self-titrate [cannabis dosing](https://cedclinic.com/medical-cannabis-safety-facts/) based on perceived effects rather than measured THC content, healthcare providers should maintain a high index of suspicion for cannabis-related adverse effects in patients presenting with sudden symptom changes and conduct a thorough product-use history, 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Minnesota+cannabis+officials+recall+Tidal+Wave+THC+vapes+for+high+THC+content+-+KSTP+%40drcaplan&url=https%3A%2F%2Fkstp.com%2Fkstp-news%2Flocal-news%2Fminnesota-cannabis-officials-recall-tidal-wave-thc-vapes-for-high-thc-content%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fkstp.com%2Fkstp-news%2Flocal-news%2Fminnesota-cannabis-officials-recall-tidal-wave-thc-vapes-for-high-thc-content%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Minnesota+cannabis+officials+recall+Tidal+Wave+THC+vapes+for+high+THC+content+-+KSTP+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fkstp.com%2Fkstp-news%2Flocal-news%2Fminnesota-cannabis-officials-recall-tidal-wave-thc-vapes-for-high-thc-content%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://kstp.com/kstp-news/local-news/minnesota-cannabis-officials-recall-tidal-wave-thc-vapes-for-high-thc-content/](https://kstp.com/kstp-news/local-news/minnesota-cannabis-officials-recall-tidal-wave-thc-vapes-for-high-thc-content/) Further Reading CED Clinic Blog[Alabama Medical Cannabis Commission audit finds violations, $200K overpayment – WBRC](https://cedclinic.com/alabama-medical-cannabis-commission-audit-violations/) Research Digest[Research Digest: 20 Recent Studies – March 19, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) Evidence Watch[Comprehensive Review Reveals Cannabis Use Disorder Affects 10% of World’s 193 Million Cannabis Users](https://cedclinic.com/cannabis-use-disorder-epidemiology-global-review/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Office of Cannabis Management issues consumer advisory for Tidal Wave brand vapes](https://cedclinic.com/cannabis-product-safety-advisories-tidal-wave-vape-alert/) Official advisory on Tidal Wave vape recall detailing safety concerns and regulatory actions. [Read Advisory](https://cedclinic.com/cannabis-product-safety-advisories-tidal-wave-vape-alert/) [Ohio cannabis recall issued after product failed to meet testing requirements](https://cedclinic.com/cbd-gummies-ohio-practical-guide-health-conscious-users/) Insights into cannabis product recalls due to testing failures and [consumer safety](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) implications. [Learn More](https://cedclinic.com/cbd-gummies-ohio-practical-guide-health-conscious-users/) [Missouri attorney general warns of unsafe, mislabeled cannabis products | ksdk.com](https://cedclinic.com/missouri-cannabis-product-safety-warning/) Warning on mislabeled cannabis products highlighting risks similar to vape recalls. [View Warning](https://cedclinic.com/missouri-cannabis-product-safety-warning/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).